控制症状 控制症状
Gilberto Barranco-Lampón1,2, Raúl Martínez-Castro3, Luara Arana-Luna4
1Servicio de Hematología, Hospital General de México, Ciudad de México, México.
概括
患有骨髓增殖性新生瘤 (MPN) 的患者通常因炎症性细胞因子增加而患有衰弱症状. 控制这些症状是治疗的关键目标,除了预防并发症之外.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 内部医学 内部医学
背景情况:
- 骨髓增殖性瘤 (MPN) 与各种并发症有关,包括壮症,微血管问题和血栓事件.
- 患有MPN的患者经常报告显著的症状负担.
- 高水平的循环炎性细胞因子显著增加了MPN的症状负担.
研究的目的:
- 突出炎症性细胞因子对MPN患者症状负担的重大影响.
- 强调症状控制的重要性,作为MPN管理中的首要治疗目标.
主要方法:
- 对MPN病理生理学和症状学现有文献的综述.
- 分析炎症性细胞因子在MPN相关症状中的作用.
- 评估MPN目前的治疗策略.
主要成果:
- 炎症性细胞因子是MPN症状的主要驱动因素.
- 在MPN中,症状负担显著影响患者的生活质量.
- 有效的MPN治疗需要解决并发症和症状.
结论:
- 症状控制是全面的MPN管理的关键组成部分.
- 向炎症性细胞因子可能是改善MPN患者生活质量的治疗策略.
相关概念视频
Controls in Experiments
7.8K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
7.8K
Pleural Effusion II: Symptoms and Management
200
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
200
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Drug Therapy
60
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
60
COPD: Management Using Bronchodilators and Corticosteroids
236
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
236


